Researchers suggested these findings could be used as a noninvasive tool in creating more personalized treatment options for patients facing a cancer diagnosis that is invasive in nature. 

The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

Twenty-five state societies have voiced their support for the proposal, being presented at the 2023 ACR Annual Meeting in D.C. 

“These evidence-based updates should spur more-informed doctor-patient conversations and help providers save more lives," the document's lead author said. 

Artificial intelligence applied to portable breast US can reduce about half of unnecessary referrals for benign lesions, experts wrote in Radiology. 

Breast density is known to drop over time, but the rate at which density decreases merits special attention, as it could be associated with a woman’s chance of developing cancer.

University Park OBGYN had its accreditation revoked effective in September, with the facility opting not to appeal the ruling, the FDA said.  

A team of experts recently developed the new system to differentiate between malignant and benign "second look" lesions on MRI for women with known breast cancer.